Anika Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Anika Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Anika Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $18.1M.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $18.1M +$18.1M Dec 31, 2023 10-K 2024-03-15
Q2 2023 $1.2M Jun 30, 2023 10-Q 2023-08-08
Q4 2022 $0 $0 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $0 Sep 30, 2022 10-Q 2022-11-09
Q4 2021 $0 -$857K -100% Dec 31, 2021 10-K 2022-03-11
Q4 2020 $857K +$857K Dec 31, 2020 10-K 2022-03-11
Q3 2020 $500K +$500K Sep 30, 2020 10-Q 2020-11-05
Q1 2020 $0 $0 Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $0 $0 Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 $0 $0 Sep 30, 2019 10-Q 2019-10-28
Q2 2019 $0 $0 Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $0 $0 Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $0 $0 Dec 31, 2018 10-Q 2019-10-28
Q3 2018 $0 $0 Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $0 $0 Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $0 $0 Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $0 $0 Dec 31, 2017 10-Q 2018-10-26
Q3 2017 $0 $0 Sep 30, 2017 10-Q 2017-10-27
Q2 2017 $0 $0 Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $0 $0 Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $0 $0 Dec 31, 2016 10-Q 2017-10-27
Q3 2016 $0 $0 Sep 30, 2016 10-Q 2016-11-01
Q2 2016 $0 $0 Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $0 Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $0 $0 Dec 31, 2015 10-Q 2016-11-01
Q3 2015 $0 Sep 30, 2015 10-Q 2015-11-03
Q2 2015 $0 Jun 30, 2015 10-Q 2015-08-04
Q4 2014 $0 $0 Dec 31, 2014 10-Q 2015-11-03
Q4 2013 $0 Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.